Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence.
Riviere-Cazaux C, Carlstrom LP, Neth BJ, Olson IE, Rajani K, Rahman M, Ikram S, Mansour MA, Mukherjee B, Warrington AE, Short SC, von Zglinicki T, Brown DA, Burma S, Tchkonia T, Schafer MJ, Baker DJ, Kizilbash SH, Kirkland JL, Burns TC. Riviere-Cazaux C, et al. Among authors: warrington ae. NPJ Precis Oncol. 2023 Nov 29;7(1):126. doi: 10.1038/s41698-023-00476-8. NPJ Precis Oncol. 2023. PMID: 38030881 Free PMC article. Review.
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomas.
Riviere-Cazaux C, Lacey JM, Carlstrom LP, Laxen WJ, Munoz-Casabella A, Hoplin MD, Ikram S, Zubair AB, Andersen KM, Warrington AE, Decker PA, Kaufmann TJ, Campian JL, Eckel-Passow JE, Kizilbash SH, Tortorelli S, Burns TC. Riviere-Cazaux C, et al. Among authors: warrington ae. medRxiv [Preprint]. 2023 Mar 2:2023.03.01.23286412. doi: 10.1101/2023.03.01.23286412. medRxiv. 2023. Update in: Neurooncol Adv. 2023 May 11;5(1):vdad061. doi: 10.1093/noajnl/vdad061 PMID: 36909488 Free PMC article. Updated. Preprint.
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas.
Riviere-Cazaux C, Lacey JM, Carlstrom LP, Laxen WJ, Munoz-Casabella A, Hoplin MD, Ikram S, Zubair AB, Andersen KM, Warrington AE, Decker PA, Kaufmann TJ, Campian JL, Eckel-Passow JE, Kizilbash SH, Tortorelli S, Burns TC. Riviere-Cazaux C, et al. Among authors: warrington ae. Neurooncol Adv. 2023 May 11;5(1):vdad061. doi: 10.1093/noajnl/vdad061. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37313502 Free PMC article. No abstract available.
The dynamic impact of location and resection on the glioma CSF proteome.
Riviere-Cazaux C, Graser CJ, Warrington AE, Hoplin MD, Andersen KM, Malik N, Palmer EA, Carlstrom LP, Dasari S, Munoz-Casabella A, Ikram S, Ghadimi K, Himes BT, Jusue-Torres I, Sarkaria JN, Meyer FB, Van Gompel JJ, Kizilbash SH, Sener U, Michor F, Campian JL, Parney IF, Burns TC. Riviere-Cazaux C, et al. Among authors: warrington ae. medRxiv [Preprint]. 2024 May 16:2024.05.15.24307463. doi: 10.1101/2024.05.15.24307463. medRxiv. 2024. PMID: 38798641 Free PMC article. Preprint.
A field resource for the glioma cerebrospinal fluid proteome: impacts of resection and location on biomarker discovery.
Riviere-Cazaux C, Graser CJ, Warrington AE, Hoplin MD, Andersen KM, Malik N, Palmer EA, Carlstrom LP, Dasari S, Munoz-Casabella A, Ikram S, Ghadimi K, Himes BT, Jusue-Torres I, Sarkaria JN, Meyer FB, Van Gompel JJ, Kizilbash SH, Sener U, Michor F, Campian JL, Parney IF, Burns TC. Riviere-Cazaux C, et al. Among authors: warrington ae. Neuro Oncol. 2024 Dec 30:noae277. doi: 10.1093/neuonc/noae277. Online ahead of print. Neuro Oncol. 2024. PMID: 39786485
A Hitchhiker's Guide Toward CSF Biomarkers for Neuro-Oncology.
Riviere-Cazaux C, Keough MB, Zuccato JA, Kumar R, Schulz S, Warrington AE, Ruff MW, Ellingson BM, Sanai N, Campian JL, Kizilbash SH, Parney IF, Zadeh G, Khasraw M, Kessler T, Sener U, Cahill DP, Mansouri A, Burns TC. Riviere-Cazaux C, et al. Among authors: warrington ae. Neuro Oncol. 2024 Dec 30:noae276. doi: 10.1093/neuonc/noae276. Online ahead of print. Neuro Oncol. 2024. PMID: 39786477
DNA aptamers that modulate biological activity of model neurons.
Rolli J, Pearson K, Wilbanks B, Hrstka SCL, Minotti AP, Studer L, Warrington AE, Staff NP, Maher LJ 3rd. Rolli J, et al. Among authors: warrington ae. Mol Ther Nucleic Acids. 2024 Nov 16;35(4):102392. doi: 10.1016/j.omtn.2024.102392. eCollection 2024 Dec 10. Mol Ther Nucleic Acids. 2024. PMID: 39720700 Free PMC article.
Longitudinal glioma monitoring via cerebrospinal fluid cell-free DNA.
Riviere-Cazaux C, Dong X, Mo W, Kumar R, Dai C, Carlstrom LP, Munoz-Casabella A, Ghadimi K, Nesvick CL, Andersen KM, Hoplin MD, Canaday N, Jusue-Torres I, Malik N, Campian JL, Ruff MW, Uhm JH, Eckel-Passow JE, Kaufmann TJ, Routman DM, Kizilbash SH, Sener U, Warrington AE, Jenkins RB, Du P, Jia S, Burns TC. Riviere-Cazaux C, et al. Among authors: warrington ae. Clin Cancer Res. 2024 Dec 23. doi: 10.1158/1078-0432.CCR-24-1814. Online ahead of print. Clin Cancer Res. 2024. PMID: 39715486
An Injury-like Signature of the Extracellular Glioma Metabolome.
Ha Y, Rajani K, Riviere-Cazaux C, Rahman M, Olson IE, Gharibi Loron A, Schroeder MA, Rodriguez M, Warrington AE, Burns TC. Ha Y, et al. Among authors: warrington ae. Cancers (Basel). 2024 Jul 30;16(15):2705. doi: 10.3390/cancers16152705. Cancers (Basel). 2024. PMID: 39123433 Free PMC article.
78 results